Nothing Special   »   [go: up one dir, main page]

JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting

Others

Items 1-10 of 316

Page
per page
  1. A-769662
    A3963 A-769662
     4 Citation
    Summary: AMPK activator,potent and reversible
      insoluble in EtOH; insoluble in H2O; ≥18.02 mg/mL
  2. Edaravone
    A5059 Edaravone
    Summary: A radical scavenger and antioxidant
  3. Melatonin
    A2842 Melatonin
    Summary: Melatonin receptors agonist
      ≥23.2 mg/mL
  4. Acarbose
    A2431 Acarbose
    Summary: Alpha-glucosidase inhibitor
      ≥64.48 mg/mL
  5. Adapalene
    A1267 Adapalene
    Target: RARs
    Summary: RARβ and RARγ agonist
      insoluble in H2O; insoluble in EtOH; ≥10.31 mg/mL
  6. Pamidronate Disodium
    A2456 Pamidronate Disodium
    Summary: Bisphosphonate antiresorptive agent & bone resorption inhibitor
      insoluble in EtOH; insoluble in DMSO; ≥13.95 mg/mL
  7. PA-824
    A1736 PA-824
    Summary: Anti-tuberculosis drug
      insoluble in EtOH; insoluble in H2O; ≥17.85 mg/mL
  8. BTZ043 Racemate
    A5118 BTZ043 Racemate
     2 Citation
    Target: DprE
    Summary: DprE1 inhibitor
      insoluble in H2O; ≥10.4 mg/mL
  9. Dimesna
    A1652 Dimesna
    Summary: Uroprotective agent
      insoluble in EtOH; ≥16.35 mg/mL
  10. Sulfasalazine
    A5770 Sulfasalazine
    Summary: NF-κB activation inhibitor
      insoluble in ETOH; insoluble in H2O; ≥17.7 mg/mL

Items 1-10 of 316

Page
per page
Relate Categories
Specificity
  1. Selective42item
  2. Non-Selective1 item
Reversibility
  1. Irreversible1 item
Target
  1. MMP1 item
  2. Voltage-gated Potassium (KV) Channels1 item
  3. Farnesoid X receptors (FXRs)1 item
  4. P-glycoprotein (P-gp)1 item
  5. Neuraminidases (NA)1 item
  6. RARs1 item
  7. Microtubules/Tubulins1 item
  8. AMPK1 item
  9. eIF4E/eIF3G interaction1 item
  10. Topoisomerases1 item
  11. Cytochrome P450 (CYP450)1 item
  12. Toll-like receptors (TLRs)1 item
  13. BMI-11 item
  14. MLK31 item
  15. Protease-Activated Receptors1 item
  16. Calcium chelator1 item
  17. Dehydrogenase1 item
  18. BCPCF efflux1 item
  19. D1 and D5 Receptors1 item
  20. D2 Receptors1 item
  21. D3 Receptors1 item
  22. Angiotensin-Converting Enzymes (ACEs)1 item
  23. Autophagy1 item
  24. COX1 item
  25. C5a receptors1 item
  26. YAP1 item
  27. eIF4F1 item
  28. Glutaminases2item
  29. Carbonic Anhydrases3item
  30. BLM1 item
  31. NADPH Oxidases1 item
  32. TAK11 item
  33. Histamine H1 Receptors1 item
  34. DYRK1 item
  35. Ionophores1 item
  36. MNK1 item
  37. eEF-21 item
  38. Inward Rectifier Potassium (Kir) Channels1 item
  39. fibrinolysis1 item
  40. D4 Receptors1 item
  41. Aldosterone receptor1 item
  42. Hydroxylases1 item
  43. Antioxidants1 item
  44. ATGL1 item
  45. AChR1 item
  46. calcium uptake1 item
  47. haspin kinase1 item
  48. STK1 item
  49. GABA receptors1 item
  50. Vitamin D receptors (VDRs)1 item
  51. Pregnane X receptor(PXR)1 item
  52. ICAM1 item
  53. sodium chloride cotransporter1 item
  54. DprE1 item
  55. Histone Methyltransferase1 item
Reported Experiments
  1. Animal Experiments55item
  2. Cell Experiments51item
Related Disease
  1. Acute Myeloid Leukemia2item
  2. Bladder Cancer1 item
  3. Brain Injuries Studies1 item
  4. Breast Cancer4item
  5. Cancer17item
  6. Colon Cancer2item
  7. Colorectal Cancer2item
  8. Dyslipidemia1 item
  9. Glioblastoma1 item
  10. Glioma1 item
  11. HIV2item
  12. Inflammatory Diseases4item
  13. Lung Cancer3item
  14. Lymphoma2item
  15. Osteoporosis1 item
  16. Pancreatic Cancer1 item
  17. Schizophrenia1 item
  18. Tuberculosis1 item